Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,311 | 114,322 | 49,060 | 64,133 | 37,394 |
| Marketable Securities | 465,641 | 448,198 | 309,502 | 347,388 | 189,838 |
| Receivables | 15,077 | 10,836 | 9,464 | 5,974 | 3,786 |
| Inventories | 7,769 | 8,070 | 4,623 | 7,272 | 3,948 |
| TOTAL | $576,230 | $592,033 | $391,965 | $431,013 | $240,989 |
| Non-Current Assets | |||||
| PPE Net | 9,111 | 8,910 | 9,062 | 9,641 | 10,471 |
| Investments And Advances | 13,836 | 42,673 | 0 | 15,109 | 0 |
| Intangibles | 197,797 | 197,797 | 197,797 | 197,797 | 197,797 |
| Other Non-Current Assets | 28,915 | 28,592 | 28,200 | 27,219 | 489,709 |
| TOTAL | $249,659 | $277,972 | $235,059 | $249,766 | $697,977 |
| Total Assets | $825,889 | $870,005 | $627,024 | $680,779 | $938,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50,213 | 52,378 | 62,290 | 61,909 | 81,833 |
| Other current liabilities | 2,750 | 88,327 | 7,750 | 6,250 | 18,850 |
| TOTAL | $52,963 | $140,705 | $70,040 | $68,159 | $100,683 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 190,410 | 187,062 | 183,513 | 176,848 | 380,616 |
| TOTAL | $211,031 | $207,683 | $204,134 | $202,940 | $571,391 |
| Total Liabilities | $263,994 | $348,388 | $274,174 | $271,099 | $672,074 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 189,135 | 188,471 | 186,891 | 166,269 | 164,566 |
| Common Shares | 1,939 | 1,929 | 1,721 | 1,707 | 1,485 |
| Retained earnings | -1,174,978 | -1,113,143 | -1,063,610 | -994,402 | -882,737 |
| Other shareholders' equity | 11,069 | 11,352 | 13,981 | 14,608 | 15,915 |
| TOTAL | $561,895 | $521,617 | $352,850 | $409,680 | $266,892 |
| Total Liabilities And Equity | $825,889 | $870,005 | $627,024 | $680,779 | $938,966 |